Patents by Inventor Jie Eun Park

Jie Eun Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11033532
    Abstract: The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can more effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: June 15, 2021
    Assignee: HK INNO.N CORPORATION
    Inventors: Ha Jin Lee, Bong Tae Kim, Hyun Kim, Ji Yeon Nam, Jie Eun Park, Geun Seog Song, Shin Young Ryu, Shinichi Koizumi, Nobuyuki Takahashi, Masaomi Tajimi
  • Publication number: 20200069652
    Abstract: The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can more effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
    Type: Application
    Filed: November 7, 2019
    Publication date: March 5, 2020
    Applicants: CJ HEALTHCARE CORPORATION, RaQualia Pharma Inc.
    Inventors: Ha Jin LEE, Bong Tae KIM, Hyun KIM, Ji Yeon NAM, Jie Eun PARK, Geun Seog SONG, Shin Young RYU, Shinichi KOIZUMI, Nobuyuki TAKAHASHI, Masaomi TAJIMI
  • Patent number: 10512635
    Abstract: The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can mere effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: December 24, 2019
    Assignees: CJ Healthcare Corporation, RaQualia Pharma Inc.
    Inventors: Ha Jin Lee, Bong Tae Kim, Hyun Kim, Ji Yeon Nam, Jie Eun Park, Geun Seog Song, Shin Young Ryu, Shinichi Koizumi, Nobuyuki Takahashi, Masaomi Tajimi
  • Publication number: 20190262409
    Abstract: The present disclosure relates to a novel Lactobacillus sakei strain and a composition comprising the same.
    Type: Application
    Filed: April 1, 2019
    Publication date: August 29, 2019
    Applicant: CJ Cheiljedang Corporation
    Inventors: Da Hye JEONG, Young Mee CHUNG, Bong Joon KIM, So Young KIM, Hyun Sun YUN, Byoung Seok MOON, Jie Eun PARK, Gi Duk BAE, Hee Yoon AHN, Jae Ho JANG
  • Publication number: 20180338954
    Abstract: The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can mere effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
    Type: Application
    Filed: June 8, 2016
    Publication date: November 29, 2018
    Applicants: CJ HEALTHCARE CORPORATION, RaQualia Pharma Inc.
    Inventors: Ha Jin LEE, Bong Tae KIM, Hyun KIM, Ji Yeon NAM, Jie Eun PARK, Geun Seog SONG, Shin Young RYU, Shinichi KOIZUMI, Nobuyuki TAKAHASHI, Masaomi TAJIMI
  • Patent number: 7781592
    Abstract: A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: August 24, 2010
    Assignee: CJ Cheiljedang Corporation
    Inventors: Il Hwan Cho, Myeong Yun Chae, Young Hoon Kim, Kyu Jeong Yeon, Chun Seon Lyu, Jong Hoon Kim, Sung Hak Jung, Sang Wook Park, Hyung Chul Ryu, Ji Young Noh, Hyun Jung Park, Jie Eun Park, Young Mee Chung
  • Patent number: 7473700
    Abstract: A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: January 6, 2009
    Assignee: CJ Corporation
    Inventors: Il Hwan Cho, Dong Hyun Ko, Myeong Yun Chae, In Ki Min, Young Hoon Kim, Kyu Jeong Yeon, Jong Hoon Kim, Sung Hak Jung, Sang Wook Park, Il Hwan Kim, Hyung Chul Ryu, Ji Young Noh, Hyun Jung Park, Jie Eun Park, Young Mee Chung
  • Publication number: 20080090875
    Abstract: A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided.
    Type: Application
    Filed: November 25, 2003
    Publication date: April 17, 2008
    Applicant: CJC Corporation
    Inventors: Il Hwan Cho, Myeong Yun Chae, Young Hoon, Kyu Jeong Yeon, Chun Seon Lyu, Jong Hoon Kim, Sung Hak Jung, Sang Wook Park, Hyung Chul Ryu, Ji Young Noh, Hyun Jung Park, Jie Eun Park, Young Mee Chung
  • Patent number: 7230010
    Abstract: A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided: wherein: R1 represents naphthyl, indolyl, benzofuranyl, benzothienyl, benzimidazolyl, benzothiazolyl, benzotriazolyl, benzooxazolyl, quinolinyl, or isoquinolinyl; wherein, R1 is optionally substituted at a substitutable position with one or more radicals independently selected from halogen, hydroxy, nitro, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, cyano, amino, monoalkylamino, and dialkylamino; R2 represents methyl or amino; and A, B, E, and D each independently represent carbon or nitrogen.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: June 12, 2007
    Assignee: CJ Corp.
    Inventors: Il Hwan Cho, Dong Hyun Ko, Myeong Yun Chae, Taerho Kim, Kyoung Rae Kang, Jong Hoon Kim, Sung Hak Jung, Sang Wook Park, Hyung Ok Chun, Hyung Chul Ryu, Ji Young Noh, Hyun Jung Park, Jie Eun Park, Young Mee Chung
  • Patent number: 6849652
    Abstract: A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided: wherein, Ar represents naphthyl; 3,4-methylenedioxyphenyl: phenyl; or phenyl substituted with the group selected from C1-C6 alkyl, C1-C6 alkoxy, or halogen.
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: February 1, 2005
    Assignee: CJ Corp.
    Inventors: Il Hwan Cho, Dong Hyun Ko, Myeong Yun Chae, Taerho Kim, Kyoung Rae Kang, Jong Hoon Kim, Sung Hak Jung, Sang Wook Park, Hyung Ok Chun, Hyung Chul Ryu, Ji Young Noh, Hyun Jung Park, Jie Eun Park, Young Mee Chung
  • Publication number: 20040106612
    Abstract: A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided: 1
    Type: Application
    Filed: August 1, 2003
    Publication date: June 3, 2004
    Inventors: Il Hwan Cho, Dong Hyun Ko, Myeong Yun Chae, Taerho Kim, Kyoung Rae Kang, Jong Hoon Kim, Sung Hak Jung, Sang Wook Park, Hyung Ok Chun, Hyung Chul Ryu, Ji Young Noh, Hyun Jung Park, Jie Eun Park, Young Mee Chung